1. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling

   • Xiaoman Zhang
   • Cuicui Xu
   • Lianghai Wang

   Research 24 February 2024 Pages: 81 - 90

   

2. Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model

   • Negar Pourjamal
   • Narjes Yazdi
   • Mark Barok

   Research Open access 17 February 2024 Pages: 91 - 102

   

3. Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models

   • Marie-Therese Haider
   • Vera Freytag
   • Tobias Lange

   Research Open access 14 February 2024 Pages: 103 - 115

   

4. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

   • Michele Maffezzoli
   • Matteo Santoni
   • Sebastiano Buti

   Research Open access 16 February 2024 Pages: 117 - 129

   

5. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

   • Anton Burkhard-Meier
   • Vindi Jurinovic
   • Lars H. Lindner

   Research Open access 29 February 2024 Pages: 131 - 141

   

6. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics

   • Shengcai Wei
   • Xinyi Gou
   • Yi Wang

   Research 28 February 2024 Pages: 143 - 154

   

7. Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection

   • Joshua S. Suppree
   • Siddarth Kannan
   • Rasheed Zakaria

   Correspondence 14 February 2024 Pages: 155 - 157